PB
PharmaCyte Biotech Inc
🇺🇸XNAS.PMCBUnited StatesHealthcare
$0.34USDdown -0.05 (-12.82%)OpenEnd of day2:25 PM
Price$0.34-0.05 (-12.82%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US71715X2036
- CUSIP
- 71715X203
Company
- Employees
- 2
- Headquarters
- Las Vegas, United States
- Website
- https://pharmacyte.com
- CEO
- Mr. Joshua N. Silverman
Market
- Shares outstanding
- 10.7M
- Market cap
- $3.65M
Highlights
- Market cap
- $3.65M
- EPS LTM
- -$1.81calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.19calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 5.25%
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$19.42M-163.36%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$5.15M-73.02%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.